{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:49:11Z","timestamp":1780595351784,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,12,14]],"date-time":"2009-12-14T00:00:00Z","timestamp":1260748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,12,14]],"date-time":"2009-12-14T00:00:00Z","timestamp":1260748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1038\/bmt.2009.349","type":"journal-article","created":{"date-parts":[[2009,12,14]],"date-time":"2009-12-14T17:24:04Z","timestamp":1260811444000},"page":"1287-1293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome"],"prefix":"10.1038","volume":"45","author":[{"given":"S H","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K H","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K W","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H H","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y J","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B-K","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y Y","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Y","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H S","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,14]]},"reference":[{"key":"BFbmt2009349_CR1","first-page":"467","volume":"7","author":"MF Ozkaynak","year":"1991","unstructured":"Ozkaynak MF, Weinberg K, Kohn D, Sender L, Parkman R, Lenarsky C . Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. Bone Marrow Transplant 1991; 7: 467\u2013474.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.bmt.1704069","volume":"32","author":"CC Barker","year":"2003","unstructured":"Barker CC, Butzner JD, Anderson RA, Brant R, Sauve RS . Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2003; 32: 79\u201387.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR3","first-page":"1396","volume":"90","author":"S Cesaro","year":"2005","unstructured":"Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G et al. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica 2005; 90: 1396\u20131404.","journal-title":"Haematologica"},{"key":"BFbmt2009349_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/bmt.2008.186","volume":"42","author":"A Cacchione","year":"2008","unstructured":"Cacchione A, LeMaitre A, Couanet DV, Benhamou E, Amoroso L, Simonnard N et al. Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen. Bone Marrow Transplant 2008; 42: 449\u2013454.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR5","first-page":"197","volume":"10","author":"HM Shulman","year":"1992","unstructured":"Shulman HM, Hinterberger W . Hepatic veno-occlusive disease\u2014liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197\u2013214.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR6","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/sj.bmt.1701506","volume":"22","author":"S Hasegawa","year":"1998","unstructured":"Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T et al. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors. Bone Marrow Transplant 1998; 22: 1191\u20131197.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.1993.11.2.304","volume":"11","author":"JP Radich","year":"1993","unstructured":"Radich JP, Sanders JE, Buckner CD, Martin PJ, Petersen FB, Bensinger W et al. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. J Clin Oncol 1993; 11: 304\u2013313.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009349_CR8","first-page":"3599","volume":"92","author":"E Carreras","year":"1998","unstructured":"Carreras E, Bertz H, Arcese W, Vernant JP, Tom\u00e1s JF, Hagglund H et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood 1998; 92: 3599\u20133604.","journal-title":"Blood"},{"key":"BFbmt2009349_CR9","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1182\/blood-2003-01-0255","volume":"102","author":"M Wadleigh","year":"2003","unstructured":"Wadleigh M, Richardson PG, Zahrieh D, Lee SJ, Cutler C, Ho V et al. Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation. Blood 2003; 102: 1578\u20131582.","journal-title":"Blood"},{"key":"BFbmt2009349_CR10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/sj.bmt.1702376","volume":"25","author":"D Valteau-Couanet","year":"2000","unstructured":"Valteau-Couanet D, Benhamou E, Vassal G, Stambouli F, Lapierre V, Couanet D et al. Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma. Bone Marrow Transplant 2000; 25: 937\u2013942.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR11","first-page":"135","volume":"10","author":"V M\u00e9resse","year":"1992","unstructured":"M\u00e9resse V, Hartmann O, Vassal G, Benhamou E, Valteau-Couanet D, Brugieres L et al. Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant 1992; 10: 135\u2013141.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.bmt.1705485","volume":"38","author":"S Corbacioglu","year":"2006","unstructured":"Corbacioglu S, H\u00f6nig M, Lahr G, St\u00f6hr S, Berry G, Friedrich W et al. Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide. Bone Marrow Transplant 2006; 38: 547\u2013553.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR13","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","volume":"79","author":"M Attal","year":"1992","unstructured":"Attal M, Huguet F, Rubie H, Huynh A, Charlet JP, Payen JL et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial. Blood 1992; 79: 2834\u20132840.","journal-title":"Blood"},{"key":"BFbmt2009349_CR14","first-page":"407","volume":"5","author":"SI Bearman","year":"1990","unstructured":"Bearman SI, Hinds MS, Wolford JL, Petersen FB, Nugent DL, Slichter SJ et al. A pilot study of continuous infusion of heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. Bone Marrow Transplant 1990; 5: 407\u2013411.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1600-0609.1991.tb01859.x","volume":"47","author":"L Marsa-Vila","year":"1991","unstructured":"Marsa-Vila L, Gorin NC, Laporte JP, Labopin M, Dupuy-Montbrun MC, Fouillard L et al. Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation. Eur J Haematol 1991; 47: 346\u2013354.","journal-title":"Eur J Haematol"},{"key":"BFbmt2009349_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/sj.bmt.1702854","volume":"27","author":"M Simon","year":"2001","unstructured":"Simon M, Hahn T, Ford LA, Anderson B, Swinnich D, Baer MR et al. Retrospective multicenter analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin. Bone Marrow Transplant 2001; 27: 627\u2013633.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR17","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/sj.bmt.1704087","volume":"31","author":"DL Forrest","year":"2003","unstructured":"Forrest DL, Thompson K, Dorcas VG, Couban SH, Pierce R . Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study. Bone Marrow Transplant 2003; 31: 1143\u20131149.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2141.1990.tb02583.x","volume":"74","author":"E Gluckman","year":"1990","unstructured":"Gluckman E, Jolivet I, Scrobohaci ML, Devergie A, Traineau R, Bourdeau-Esperou H et al. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Br J Haematol 1990; 74: 277\u2013281.","journal-title":"Br J Haematol"},{"key":"BFbmt2009349_CR19","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3346\/jkms.2006.21.5.897","volume":"21","author":"JS Song","year":"2006","unstructured":"Song JS, Seo JJ, Moon HN, Ghim T, Im HJ . Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children. J Korean Med Sci 2006; 21: 897\u2013903.","journal-title":"J Korean Med Sci"},{"key":"BFbmt2009349_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","volume":"10","author":"Y Chalandon","year":"2004","unstructured":"Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsahin H, Wacker P et al. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 347\u2013354.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2009349_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.bmt.1705696","volume":"40","author":"F Dignan","year":"2007","unstructured":"Dignan F, Gujral D, Ethell M, Evans S, Treleaven J, Morgan G et al. Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease. Bone Marrow Transplant 2007; 40: 79\u201382.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR22","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/pbc.21425","volume":"30","author":"A Qureshi","year":"2008","unstructured":"Qureshi A, Marshall L, Lancaster D . Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children. Pediatr Blood Cancer 2008; 30: 831\u2013832.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2009349_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255\u2013267.","journal-title":"Ann Intern Med"},{"key":"BFbmt2009349_CR24","first-page":"53","volume":"3","author":"L Brugieres","year":"1988","unstructured":"Brugieres L, Hartmann O, Benhamou E, Zafrani ES, Caillaud JM, Patte C et al. Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome. Bone Marrow Transplant 1988; 3: 53\u201358.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR25","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","volume":"11","author":"SI Bearman","year":"1993","unstructured":"Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, McDonald GB . Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993; 11: 1729\u20131736.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009349_CR26","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.bmt.1701994","volume":"24","author":"HC Toh","year":"1999","unstructured":"Toh HC, McAfee SL, Sackstein R, Cox BF, Colby C, Spitzer TR . Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplant 1999; 24: 891\u2013895.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR27","first-page":"171","volume":"18","author":"MJ Styler","year":"1996","unstructured":"Styler MJ, Crilley P, Biggs J, Moul J, Copelan E, Topolsky D et al. Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis. Bone Marrow Transplant 1996; 18: 171\u2013176.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1200\/JCO.2000.18.5.981","volume":"18","author":"T Girinsky","year":"2000","unstructured":"Girinsky T, Benhamou E, Bourhis JH, Dhermain F, Guillot-Valls D, Ganansia V et al. Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. J Clin Oncol 2000; 18: 981\u2013986.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009349_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0167-8140(89)90129-1","volume":"15","author":"JM Cosset","year":"1989","unstructured":"Cosset JM, Baume D, Pico JL, Shank B, Girinski T, Benhamou E et al. Single dose versus hyperfractionated total body irradiation before allogeneic bone marrow transplantation: a non-randomized comparative study of 54 patients at the Institute Gustave-Roussy. Radiother Oncol 1989; 15: 151\u2013160.","journal-title":"Radiother Oncol"},{"key":"BFbmt2009349_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00694339","volume":"25","author":"LB Grochow","year":"1989","unstructured":"Grochow LB, Jones RJ, Brundrett RB, Braine HG, Chen TL, Saral R et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol 1989; 25: 55\u201361.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFbmt2009349_CR31","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1365-2141.2008.07399.x","volume":"143","author":"R Cutting","year":"2008","unstructured":"Cutting R, Mirelman A, Vora A . Treosulphan as an alternative to busulphan for myeloablative conditioning in paediatric allogeneic transplantation. Br J Haematol 2008; 143: 748\u2013751.","journal-title":"Br J Haematol"},{"key":"BFbmt2009349_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.bmt.1704784","volume":"35","author":"DW Beelen","year":"2005","unstructured":"Beelen DW, Trenschel R, Casper J, Freund M, Hilger RA, Scheulen ME et al. Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications. Bone Marrow Transplant 2005; 35: 233\u2013241.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR33","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1365-2141.1993.tb03152.x","volume":"84","author":"SI Bearman","year":"1993","unstructured":"Bearman SI, Shen DD, Hinds MS, Hill HA, McDonald GB . A phase I\/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation. Br J Haematol 1993; 84: 724\u2013730.","journal-title":"Br J Haematol"},{"key":"BFbmt2009349_CR34","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/225600a0","volume":"225","author":"PJ Piper","year":"1970","unstructured":"Piper PJ, Vane JR, Wyllie JH . Inactivation of prostaglandins by the lungs. Nature 1970; 225: 600\u2013604.","journal-title":"Nature"},{"key":"BFbmt2009349_CR35","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.2042-7158.1983.tb02862.x","volume":"35","author":"Y Mizushima","year":"1983","unstructured":"Mizushima Y, Yanagawa A, Hoshi K . Prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in man. J Pharm Pharmacol 1983; 35: 666\u2013667.","journal-title":"J Pharm Pharmacol"},{"key":"BFbmt2009349_CR36","first-page":"1206","volume":"36","author":"AK Sim","year":"1986","unstructured":"Sim AK, McCraw AP, Cleland ME, Aihara H, Otomo S, Hosoda K . The effect of prostaglandin E1 incorporated in lipid microspheres on thrombus formation and thrombus disaggregation and its potential to target to the site of vascular lesions. Arzneimittelforschung 1986; 36: 1206\u20131209.","journal-title":"Arzneimittelforschung"},{"key":"BFbmt2009349_CR37","first-page":"627","volume":"11","author":"S Otomo","year":"1985","unstructured":"Otomo S, Mizushima Y, Aihara H, Yokoyama K, Watanabe M, Yanagawa A . Prostaglandin E1 incorporated in lipid microspheres (lipo PGE1). Drugs Exp Clin Res 1985; 11: 627\u2013631.","journal-title":"Drugs Exp Clin Res"},{"key":"BFbmt2009349_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0952-3278(90)90141-7","volume":"41","author":"Y Mizushima","year":"1990","unstructured":"Mizushima Y, Hamano T, Haramoto S, Kiyokawa S, Yanagawa A, Nakura K et al. Distribution of lipid microspheres incorporating prostaglandin E1 to vascular lesions. Prostaglandins Leukot Essent Fatty Acids 1990; 41: 269\u2013272.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"BFbmt2009349_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/sj.bmt.1704591","volume":"34","author":"AM Evens","year":"2004","unstructured":"Evens AM, Mehta J, Gordon LI . Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transplant 2004; 34: 561\u2013571.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009349_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJM199808133390701","volume":"339","author":"NF Olivieri","year":"1998","unstructured":"Olivieri NF, Brittenham GM, McLaren CE, Templeton DM, Cameron RG, McClelland RA et al. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med 1998; 339: 417\u2013423.","journal-title":"N Engl J Med"},{"key":"BFbmt2009349_CR41","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1056\/NEJM199409013310903","volume":"331","author":"NF Olivieri","year":"1994","unstructured":"Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A et al. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 1994; 331: 574\u2013578.","journal-title":"N Engl J Med"},{"key":"BFbmt2009349_CR42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/10245332.1999.11746478","volume":"4","author":"M Morado","year":"2000","unstructured":"Morado M, Ojeda E, Garcia-Bustos J, Aguado MJ, Arrieta R, Quevedo E et al. BMT: serum ferritin as risk factor for veno-occlusive disease of the liver. Prospective Cohort Study. Hematology 2000; 4: 505\u2013512.","journal-title":"Hematology"},{"key":"BFbmt2009349_CR43","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1182\/blood-2006-10-054924","volume":"109","author":"P Armand","year":"2007","unstructured":"Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007; 109: 4586\u20134588.","journal-title":"Blood"},{"key":"BFbmt2009349_CR44","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/pbc.21260","volume":"50","author":"W Jastaniah","year":"2008","unstructured":"Jastaniah W, Harmatz P, Pakbaz Z, Fischer R, Vichinsky E, Walters MC . Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies. Pediatr Blood Cancer 2008; 50: 319\u2013324.","journal-title":"Pediatr Blood Cancer"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2009349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009349","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:29:03Z","timestamp":1648038543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2009349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,14]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["BFbmt2009349"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2009.349","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,14]]},"assertion":[{"value":"9 March 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}